首页 > 技术支持 > 文献速递

CD38 endows local antigen-specific Treg cells with stress resilience for control of compartmentalized CNS inflammation

Nature Immunology

Foxp3-expressing regulatory T (Treg) cells protect against systemic autoimmunity. However, little is known about the significance of Tregcells in inflammation-experienced tissues. Here, we use an experimental autoimmune encephalomyelitis model and show that Tregcells accumulate and persist in the central nervous system (CNS) long after the resolution of the bulk of the inflammatory infiltrate. CNS-specific depletion of postinflammatory Tregcells, but not systemic depletion of Tregcells, results in autoimmune inflammatory flares in the CNS by residual local effector T cells. Expression of the NAD-consuming ectoenzyme CD38 is crucial for the functional adaptation of postinflammatory CNS Tregcells to a stressful microenvironment, in which access to interleukin-2 (IL-2) is limited. CD38 counteracts ADP-ribosylation of the IL-2 receptor and thus maintains its high sensitivity to IL-2. This fully functional high-affinity IL-2 receptor prevents the loss of tissue-resident antigen-specific Tregcells. These 'stress-tolerant' CNS Tregcells impede the collapse of immune homeostasis in the CNS once acute inflammation is controlled.

https://doi.org/10.1038/s41590-025-02416-z

Related products

Catalog No. Product Name Description Target
HB691036 Anti-Human CD38 Reference Antibody (Mezagitamab Mezagitamab (HB691036) is a research-grade recombinant antibody targeting CD38. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns. Cyclic ADP-ribose hydrolase 1, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, T10, 2'-phospho-cyclic-ADP-ribose transferase, CD38, ADPRC 1, ADP-ribosyl cyclase 1, 2'-phospho-ADP-ribosyl cyclase